Agile_Logo-color on white.jpg
Agile Therapeutics Announces Plans to Advance Contraceptive Pipeline
12 juil. 2016 16h12 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Cohera Medical, Inc.
Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
12 juil. 2016 09h30 HE | Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Cascadian Therapeuti
Cascadian Therapeutics Receives ONT-380 Fast Track Designation from FDA for the Treatment of Advanced HER2+ Metastatic Breast Cancer
29 juin 2016 08h00 HE | Cascadian Therapeutics
SEATTLE, June 29, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that the ONT-380 program in advanced HER2+ metastatic...
New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend
21 juin 2016 11h30 HE | Industry Standard Research
CARY, NC--(Marketwired - June 21, 2016) - Industry Standard Research has released its comprehensive new report, "Phase II/III Study Trends and Market Outlook (2016-2020)," concerning the trends,...
Summit Master_rgb_png.png
Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile Infection
20 juin 2016 12h30 HE | Summit Therapeutics PLC
Microbiome-Sparing Action of Ridinilazole associated with Superiority over Vancomycin in Sustained Clinical Response Rate OXFORD, United Kingdom, June 20, 2016 (GLOBE NEWSWIRE) -- Summit...
Summit Master_rgb_png.png
First Patient Enrolled in Summit’s PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys With DMD
17 juin 2016 07h00 HE | Summit Therapeutics PLC
OXFORD, United Kingdom, June 17, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular...
Achillion-Logo-150 (4).jpg
Achillion Presents Interim Phase 1 Results for ACH-4471, a Novel Orally-Administered Factor D Inhibitor, at the 21st Congress of the European Hematology Association
10 juin 2016 03h30 HE | Achillion Pharmaceuticals, Inc.
-  Results indicate up to 100% inhibition of alternative-pathway (AP) activity in hemolysis and Wieslab assays after oral dosing of ACH-4471  - -  Results support initiation...
Provista Diagnostics
Provista Diagnostics Announces Positive Trial Results Assessing the Use of Videssa® Breast to Detect Breast Cancer
02 juin 2016 08h00 HE | Provista Diagnostics, Inc.
NEW YORK, June 02, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women,...
Protalix BioTherapeutics to Present at the Jefferies 2016 Global Healthcare Conference
02 juin 2016 07h30 HE | Protalix BioTherapeutics, Inc.
CARMIEL, Israel, June 02, 2016 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), today announced that Moshe Manor, the Company's President and Chief Executive...
med-hero-5K_01
CISCRP Medical Heroes Appreciation 5K Event Will Bring Together Research Professionals and the Public to Honor Clinical Trial Volunteers
24 mai 2016 08h35 HE | CISCRP
PHILADELPHIA, PA., May 24, 2016 (GLOBE NEWSWIRE) -- The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization, is excited to announce its...